AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Biodesix at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Biodesix brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 544. Its session covers monitoring residual disease and emerging treatment resistance through blood testing. The company offers diagnostic tests supporting lung cancer decisions, plus testing services for biopharma and research organizations.
| Organization | AMP 2026 Attendance |
|---|---|
Biodesix Louisville, CO | |
Diagnostic tests supporting clinical decisions in lung cancer, plus testing capabilities and services for biopharma and research organizations. | Booth Exhibiting at Booth 544 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 4:00pm–4:50pm Listening for the Whisper - Monitoring Residual Disease and Emerging Resistance in the Blood Droplet digital PCR, spatial and sequencing assays used together to monitor cancer treatment response in blood and tissue. |
Find decision makers at Biodesix
Tell us what you sell and we’ll find the people at Biodesix most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction